{
  "meta": {
    "id": "test14",
    "title": "Classification & Risk Factor",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A 35-year-old woman is being evaluated for a breast mass first noticed during a routine physical examination last week. The patient had bilateral reduction mammoplasty for mammary hyperplasia 2 years ago. She takes no medications or allergies; her paternal grandmother died at age 65 of breast cancer. Breast examination shows a fixed mass palpated in the upper outer quadrant of the right breast. Mammography shows a 3 x 3 cm irregular mass with coarse calcifications in the upper outer quadrant of the right breast and an oil cyst. Ultrasonography of the breast shows a hyperechoic mass. Core biopsy shows foamy macrophages and fat globules, and the mass is excised with concordant pathologic findings. Which of the following is the most appropriate course of action in managing this patient?",
      "options": [
        {
          "label": "A",
          "text": "Neoadjuvant chemotherapy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Reassurance and routine follow up",
          "correct": true
        },
        {
          "label": "C",
          "text": "Simple Mastectomy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Modified Radical Mastectomy",
          "correct": false
        }
      ],
      "correct_answer": "B. Reassurance and routine follow up",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Reassurance and routine follow up This patient most likely has fat necrosis of the breast . This benign condition is associated with breast surgery (e.g., breast reduction/reconstruction) and trauma (e.g., seatbelt injury). Fat necrosis can mimic breast cancer in its clinical and radiographic presentation. It commonly presents as a fixed mass with skin or nipple retraction and gives the appearance of calcifications on mammography . The presence of oil cysts on mammography is usually pathognomonic for breast fat necrosis. Ultrasonography can demonstrate a hyperechoic mass , often correlating with a benign aetiology. A biopsy is diagnostic and typically shows fat globules and foamy histiocytes. Despite benign biopsy results, the entire mass is often excised due to concerning findings of calcifications on mammography and a fixed irregular mass on clinical examination. Once the diagnosis is confirmed with pathologic analysis, routine annual screening is sufficient as the risk of breast cancer is not increased.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A. Neoadjuvant chemotherapy can decrease tumor size before surgery to allow for greater preservation of normal tissue during surgery (e.g., lumpectomy instead of mastectomy). Although breast cancer will appear as an irregular mass with microcalcifications on mammography , it tends to have a spiculated appearance without oil cysts. A biopsy would show the proliferation of cells that invade through the basement membrane, not foam cells and giant cells. Option: C. Radiation and surgery are not indicated for this non-malignant condition. Prophylactic mastectomy can be considered in patients with a strong family history of breast cancer, such as a patient with \u22651 first-degree relative before age 50 or a hereditary oncogenic mutation (BRCA1). Option: D. Modified radical mastectomy is indicated for patients with biopsy-proven breast cancer that spreads to the axillary lymph nodes . Although breast cancer will appear as an irregular mass with microcalcifications on mammography, it tends to have a spiculated appearance without oil cysts. Also, a biopsy would show the proliferation of cells that invade through the basement membrane, not foam cells and giant cells.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dc6d4cca",
      "audio": ""
    },
    {
      "text": "A 47-year-old woman comes to the physician for a mass in her left breast she noticed 2 days ago during a breast self-examination. She has hypothyroidism treated with levothyroxine. There is no family history of breast cancer. Examination shows large, moderately ptotic breasts. The mass in her left breast is small (approximately 1 cm x 0.5 cm), firm, mobile, and painless. It is located 4 cm from her nipple-areolar complex at 7 o'clock. There are no changes in the skin or nipple and no palpable axillary lymphadenopathy. No masses are palpable in her right breast. A urine pregnancy test is negative. Mammogram showed a soft tissue mass with poorly defined margins. Core needle biopsy confirms a low-grade infiltrating ductal carcinoma. The pathological specimen is positive for oestrogen receptors and negative for progesterone and human epidermal growth factor receptor 2 (HER2) receptors. Staging shows no distant metastatic disease. Which of the following is the most appropriate next step in management?",
      "options": [
        {
          "label": "A",
          "text": "Mastectomy with axillary lymph node dissection followed by hormone therapy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mastectomy with axillary lymph node dissection followed by radiation and hormone therapy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lumpectomy with sentinel lymph node biopsy followed by hormone therapy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lumpectomy with sentinel lymph node biopsy followed by radiation and hormone therapy",
          "correct": true
        }
      ],
      "correct_answer": "D. Lumpectomy with sentinel lymph node biopsy followed by radiation and hormone therapy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Lumpectomy with sentinel lymph node biopsy followed by radiation and hormone therapy This patient has early-stage , invasive breast cancer with a large breast/tumour ratio and no clinically apparent skin, nipple, or axillary lymph node involvement. Early-stage invasive breast cancer treatment involves breast-conserving therapy with lumpectomy followed by radiation therapy and sentinel lymph node biopsy to evaluate for spread. Since this patient has a hormone receptor-positive cancer, she should also receive adjuvant hormone therapy (e.g., tamoxifen).</p>\n<p><strong>Highyeild:</strong></p><p>Lumpectomy/ Breast Conservation Surgery( BCS ) - Removal of tumour with a three-dimensional clearance of a 1-cm margin of normal tissue . After a lumpectomy or partial mastectomy, radiation therapy is usually given to the whole breast over a period of several weeks. This is called whole-breast radiation therapy . The goal is to deliver a high dose of radiation to the breast tissue while minimising the radiation exposure to nearby healthy tissues.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A. Less extensive surgical excision provides the same survival outcomes for early breast cancer as mastectomy. In addition, axillary lymph node dissection can cause complications such as lymphedema and would only be indicated if the patient had a positive previous lymph node biopsy. Option: B. Although a selected group of patients may request aggressive management of early breast cancer mastectomy (NSA), less extensive surgical procedures provide the same survival outcomes with fewer complications. In early-stage breast cancer, mastectomy may be performed because of patient preference or a large tumour-to-breast ratio , neither of which is the case for this patient. Moreover, axillary lymph node dissection may cause complications such as lymphedema and would only be indicated if the patient had a positive previous lymph node biopsy. Option: C. Sentinel lymph node biopsy is indicated for all patients with no clinical signs of axillary lymph node involvement to rule out the microscopic spread and determine the cancer stage, which will determine the subsequent course of treatment. Since this patient has hormone receptor-positive cancer, she would benefit from adjuvant hormone therapy. However, all patients who undergo lumpectomy require one additional therapeutic modality to minimise the risk of recurrence.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "30a7fdf4",
      "audio": ""
    },
    {
      "text": "The patient undergoes a mammogram showing a 6.5 mm-sized mass with an irregular border and spiculated margins. A subsequent core needle biopsy of the mass shows infiltrating ductal carcinoma with HER2-positive, oestrogen-negative, and progesterone-negative immunohistochemistry staining. Blood counts and liver function tests are normal. Laboratory studies show: which of the following is the most appropriate next step in management?",
      "options": [
        {
          "label": "A",
          "text": "Breast conserving therapy and sentinel lymph node biopsy",
          "correct": true
        },
        {
          "label": "B",
          "text": "Trastuzumab Therapy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Whole body PET/CT",
          "correct": false
        },
        {
          "label": "D",
          "text": "Bilateral mastectomy with lymph node dissection",
          "correct": false
        }
      ],
      "correct_answer": "A. Breast conserving therapy and sentinel lymph node biopsy",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/questionImage-1689748197091-QTDS008003IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Breast conserving therapy and sentinel lymph node biopsy Breast-conserving therapy and sentinel node biopsy are diagnostic and therapeutic procedures used as a first-line intervention in patients with newly diagnosed invasive ductal carcinoma. All patients who undergo lumpectomy require postoperative radiation to the whole breast to minimise the risk of recurrence. Sentinel node biopsy is necessary to stage cancer, which will determine subsequent treatment. Moreover, given the HER2-positive immunohistochemical staining, this patient will benefit from adjuvant systemic chemotherapy in the form of trastuzumab.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: B. Trastuzumab is used as adjuvant chemotherapy in patients with operable, HER2 receptor-positive breast cancer, as is the case here. Although this patient should eventually undergo trastuzumab therapy, another management step is indicated at this time. Trastuzumab can be used as neoadjuvant chemotherapy in patients with evidence of locally advanced cancer (i.e., palpable axillary lymph nodes or tumor > 5 cm) or if the tumor-to-breast ratio is very large and would therefore prevent a good cosmetic outcome. Option: C. A whole-body PET/CT scan is required in all patients with stage IIIA or higher disease to assess for metastases . Additionally, patients presenting with metastatic disease signs, such as abdominal pain, elevated LFTs, or palpable abdominal masses , may benefit from a whole-body PET/CT scan. However, the stage of this patient's cancer has not yet been determined, and she does not have any signs of metastatic disease, so a whole-body PET-CT would not be indicated at this time. Option: D. A bilateral mastectomy with lymph node dissection is commonly performed in patients with bilateral disease or in patients who have a BRCA gene mutation. Although a BRCA mutation has not explicitly been ruled out in this patient, BRCA mutation carriers generally have a personal and/or family history of breast, ovarian, tubal, or peritoneal cancer. They may also have more advanced diseases at presentation (triple-negative or bilateral breast cancer). This patient does not have any of these conditions, which makes a BRCA mutation unlikely. In addition, a HER2 mutation has already been identified as the likely culprit.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b13bc890",
      "audio": ""
    },
    {
      "text": "A 49-year-old woman comes to the physician because of a growing lump in the right breast that she first noticed 1 month ago. Physical examination of the right breast shows a 3.5 cm firm, fixed mass in the right upper quadrant. There is a dimpling of the overlying skin. Mammography shows a mass with poorly-defined margins and microcalcifications. Immunohistochemical analysis of a biopsy specimen from the mass shows malignant cells that stain negative for oestrogen and progesterone receptors and positive for human epidermal growth factor receptor 2. The drug that most specifically targets this patient's tumor is also used to treat which of the following conditions?",
      "options": [
        {
          "label": "A",
          "text": "Multiple sclerosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Gastric cancer",
          "correct": true
        },
        {
          "label": "C",
          "text": "Colorectal cancer",
          "correct": false
        },
        {
          "label": "D",
          "text": "Endometrial cancer",
          "correct": false
        }
      ],
      "correct_answer": "B. Gastric cancer",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Gastric cancer Overexpression of HER2 is found in up to 20% of gastric cancers and 15\u201320% of breast cancers . HER2-positive cancers have been associated with a poor prognosis due to more aggressive tumour growth and higher recurrence rates. However, the introduction of drugs that target HER2, such as trastuzumab , has improved the prognosis. Trastuzumab blocks this receptor, which leads to growth arrest and subsequent apoptosis of cancer cells.</p>\n<p><strong>Highyeild:</strong></p><p>HER2 ( human epidermal growth factor receptor 2 ) is an overexpressed protein in some breast cancers, leading to more aggressive tumour growth. It occurs in about 20-25% of breast cancers . It is associated with a poorer prognosis and a higher risk of recurrence than breast cancers that do not overexpress HER2. HER2-positive breast cancer cells have more receptors on their surface for growth factors, which leads to increased cell growth and division.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A. Alemtuzumab is approved for disease-modifying multiple sclerosis therapy and can also be used to treat chronic lymphocytic leukaemia . Trastuzumab, however, is not indicated for multiple sclerosis. Option: C. Bevacizumab is used to treat colorectal cancer, renal cell carcinoma, non-small cell lung cancer and neovascular age-related macular degeneration . It binds to and neutralises vascular endothelial growth factor, thereby preventing angiogenesis and causing growth arrest of (tumour) cells. Although bevacizumab is sometimes used off-label as a combination therapy in the treatment of metastatic breast cancer , it would not specifically target this patient's tumour cells. Trastuzumab, on the other hand, is not indicated for colorectal cancer. Option: D. Trastuzumab has recently been evaluated in clinical trials as a treatment option for certain endometrial carcinomas , but it is not approved for that indication yet. Tamoxifen, a selective oestrogen receptor modulator, is a first-line treatment for breast cancer in premenopausal patients. Since this patient's breast cancer cells are negative for oestrogen receptors, tamoxifen would not specifically target them. In most cases, tamoxifen is associated with an increased risk of endometrial cancer due to its partial agonist effect in the endometrium. Consequently, it would not be beneficial for the treatment of endometrial cancer.</p>\n<p><strong>Extraedge:</strong></p><p>The overexpression of HER2 is detected by a test called HER2/neu testing , which is usually performed on breast cancer tissue samples. If a patient's tumor overexpresses HER2, they may be eligible for targeted therapy with drugs like trastuzumab .</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d2076ad5",
      "audio": ""
    },
    {
      "text": "A 57-year-old woman comes to the physician for evaluation of a lump in the right breast that she first noticed a week ago. A biopsy of the mass confirms a diagnosis of a pleomorphic lobular carcinoma-in-situ that is oestrogen receptor-positive. The patient undergoes a lumpectomy, and treatment with tamoxifen is initiated. Which of the following conditions is most likely to occur due to tamoxifen therapy?",
      "options": [
        {
          "label": "A",
          "text": "Endometrial Cancer",
          "correct": true
        },
        {
          "label": "B",
          "text": "Osteoporosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ovarian cancer",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cardiotoxicity",
          "correct": false
        }
      ],
      "correct_answer": "A. Endometrial Cancer",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Endometrial Cancer Long-term exposure to increased oestrogen levels is the most important risk factor for endometrial cancer. Tamoxifen is a selective oestrogen receptor modulator (SERM) that has antagonistic effects on breast tissue (which is why it is effective in treating ER-positive breast cancer) and agonistic effects on bone and uterine tissue . Studies have shown that postmenopausal women taking tamoxifen risk developing endometrial cancer that is 2\u20133 times higher than an age-matched population. Raloxifene is a SERM that does not increase the risk of endometrial cancer because it has agonistic effects on bone and antagonistic effects on both uterine and breast tissue.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: B. Tamoxifen has an antagonistic effect on oestrogen receptors in the breast tissue but an agonistic effect on oestrogen receptors in bone tissue. Since activating oestrogen receptors in bone induces osteoclast apoptosis and inhibits osteoblast apoptosis, tamoxifen therapy would reduce the risk of osteoporosis. Examples of drugs that can cause osteoporosis are glucocorticoids, proton pump inhibitors, aromatase inhibitors (e.g., anastrozole), levothyroxine, heparin, and certain anticonvulsants (e.g., carbamazepine, phenytoin, phenobarbital) Option: C. Tamoxifen can increase the incidence of benign ovarian cysts in premenopausal women, but it does not significantly increase the risk of ovarian cancer. Option: D. Cardiotoxicity is a side effect of doxorubicin and trastuzumab , both of which are used in the treatment of breast cancer. Cardiotoxicity would not be expected with tamoxifen therapy.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "90629d89",
      "audio": ""
    },
    {
      "text": "Risk factors for the development of breast cancer include all EXCEPT:",
      "options": [
        {
          "label": "A",
          "text": "Early menarche",
          "correct": false
        },
        {
          "label": "B",
          "text": "Nulliparity",
          "correct": false
        },
        {
          "label": "C",
          "text": "Late menopause",
          "correct": false
        },
        {
          "label": "D",
          "text": "Longer lactation period",
          "correct": true
        }
      ],
      "correct_answer": "D. Longer lactation period",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Longer lactation period Increased exposure to oestrogen is associated with an increased risk of developing breast cancer, whereas reducing exposure is considered protective. Moderate levels of exercise and a longer lactation period, factors that decrease the total number of menstrual cycles, are protective.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Factors that increase the number of menstrual cycles, such as early menarche, nulliparity, and late menopause, are associated with increased risk.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dfe417c2",
      "audio": ""
    },
    {
      "text": "Which of the following is true regarding breast cancer metastasis?",
      "options": [
        {
          "label": "A",
          "text": "Metastasis occurs after breast cancers acquire their blood supply",
          "correct": true
        },
        {
          "label": "B",
          "text": "Batson plexus facilitates metastasis to the lung",
          "correct": false
        },
        {
          "label": "C",
          "text": "Natural killer cells have no role in breast cancer immunosurveillance",
          "correct": false
        },
        {
          "label": "D",
          "text": "60% of women who develop breast carcinoma metastases will do so within 36 months of treatment",
          "correct": false
        }
      ],
      "correct_answer": "A. Metastasis occurs after breast cancers acquire their blood supply",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Metastasis occurs after breast cancers acquire their blood supply At approximately the 20th cell doubling, breast cancers acquire their blood supply ( neovascularisation ). Thereafter, cancer cells may be shed directly into the systemic venous blood to seed the pulmonary circulation via the axillary and intercostal veins or the vertebral column via the Batson plexus of veins, which courses the length of the vertebral column. Natural killer lymphocytes and macrophages scavenge these cells. Sixty per cent of the women who develop distant metastases will do so within 60 months of treatment.</p>\n<p><strong>Highyeild:</strong></p><p>Breast cancer metastasis refers to the spread of malignant breast cancer cells from the primary tumor site to other parts of the body, such as the l ymph nodes, liver, lungs, bones, or brain . The process of metastasis involves multiple steps, including the detachment of cancer cells from the primary tumor, invasion of surrounding tissues, penetration of blood or lymphatic vessels, and establishment of secondary tumors in distant organs.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c91edcaa",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman presents with a lump in the left breast. Her family history is negative for breast cancer. On examination, the mass is rubbery, mobile, and non-tender to palpation. There are no overlying skin changes, and the axilla is negative for lymphadenopathy. An ultrasound demonstrates a simple 1-cm cyst in the area of the palpable mass in the left breast. Which of the following represents the most appropriate management of this patient?",
      "options": [
        {
          "label": "A",
          "text": "Reassurance and re-examination",
          "correct": true
        },
        {
          "label": "B",
          "text": "Aspiration of the cyst with cytologic analysis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Immediate excisional biopsy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Mammography",
          "correct": false
        }
      ],
      "correct_answer": "A. Reassurance and re-examination",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Reassurance and re-examination Most clinicians would recommend reassurance and re-examination in this situation. Cysts are common benign lesions in the breasts of women in their thirties and forties and carry a shallow risk for malignancy. A simple cyst is rarely associated with malignancy. Ultrasound images of simple breast cysts: Diagnosis  of breast cysts is usually made through imaging studies, such as mammography or ultrasound, and confirmed with fine-needle aspiration (FNA) biopsy.</p>\n<p><strong>Highyeild:</strong></p><p>Causes of discrete breast lumps: Benign Malignant Non- inflammatory Fibroadenoma Carcinoma of the breast (invasive, DCIS) Ductal papilloma Malignant phyllodes Phyllodes Hamartoma Galactocele Breast cyst Haematoma Traumatic fat necrosis Inflammatory Breast abscess (acute inflammatory, tubercular Antibioma Periductal mastitis (evanescent mass) \u25cf     Granulomatous mastitis \u25cf     Parasitic: hydatid, filariasis \u25cf     Fungal: aspergillosis, blastomycosis, Cryptococcus, Histoplasma</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: B. Aspiration is not required for an asymptomatic cyst. A complex cyst may be associated with an underlying malignancy, and aspiration is usually recommended or a symptomatic breast cyst (ex-painful cyst) requires aspiration. If the cyst disappears with aspiration and the contents are not grossly bloody, the fluid must not be sent for cytologic analysis. If the lesion does not completely disappear or recurs multiple times after aspiration, the fluid should be sent for cytology. Option: C. Excision of a cyst is indicated if the cytologic findings are suspicious for malignancy. Option: D. In young women, the breast parenchyma is dense, limiting mammography's diagnostic value.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "52077992",
      "audio": ""
    },
    {
      "text": "Which of these following statements is false?",
      "options": [
        {
          "label": "A",
          "text": "Nipple retraction always indicates an underlying malignancy",
          "correct": true
        },
        {
          "label": "B",
          "text": "Staphylococcus aureus is the most common cause for lactational mastitis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Fibroadenomas does not usually require excision",
          "correct": false
        },
        {
          "label": "D",
          "text": "The histology of phyllodes tumour may be benign, intermediate or malignant",
          "correct": false
        }
      ],
      "correct_answer": "A. Nipple retraction always indicates an underlying malignancy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Nipple retraction always indicates an underlying malignancy Nipple retraction might be noticed during puberty when the breasts develop and the aetiology is unknown. This might cause difficulty in breastfeeding due to retained secretions. A slit-like Nipple retraction may also be seen in duct ectasia and chronic periductal mastitis.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: B. Staphylococcus aureus is the most common cause of lactational infections . Fifty per cent of infants harbour staphylococci in the nasopharynx. A cracked nipple might initiate mastitis, and blocked lactiferous ducts with stagnant milk will allow organisms to multiply, leading to breast abscess. Option: C. Fibroadenomas are not associated with a high risk of malignancy. They are offered excision only if they are large or have suspicious cytology or when a patient desires to have them removed. Option: D. Phyllodes tumour is classified histologically as benign, intermediate and malignant . The degree of stromal cellular atypia, mitotic activity per 10 high-power fields, presence or absence of stromal overgrowth (defined as a single 40 times field of pure stroma devoid of epithelium), infiltrative or expansile margins is the criteria used to sub-classify phyllodes as benign, borderline, or malignant.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "abfe0fb2",
      "audio": ""
    },
    {
      "text": "A 30-year-old woman sustained a traumatic blow to her right breast. Initially, there was a 3-cm contusion beneath the skin that resolved within 3 weeks, but she then felt a firm, painless lump that persisted below the site of the bruise 1 month later. What is the most likely diagnosis for this lump?",
      "options": [
        {
          "label": "A",
          "text": "Abscess",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fat necrosis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Fibroadenoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Inflammatory carcinoma",
          "correct": false
        }
      ],
      "correct_answer": "B. Fat necrosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Fat necrosis Fat necrosis is typically caused by trauma to the breast . The damaged, necrotic fat is phagocytosed by macrophages, which become lipid-laden. The lesion resolves as a collagenous scar within weeks to months. The firm scar can mammographically and grossly resemble a carcinoma . Breast lump showing an area of fat necrosis showing shadowy outlines of necrotic adipocytes surrounded by an inflammatory reaction with cholesterol clef ts.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A. An abscess may form a palpable but painful mass lesion, and often from Staphylococcus aureus infection when localised. Option: C. A fibroadenoma is a neoplasm, and trauma does not induce tumours. Option: D. Inflammatory carcinoma refers to dermal lymphatic invasion by an underlying breast carcinoma, giving a rough red-to-orange appearance to the skin.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "efd2ef36",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman complains of pain in her left breast for 2 weeks\u2019 duration. On examination, she has a tender string-like band with overlying prominent veins, as shown in the image. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Zuska\u2019s disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mondor\u2019s disease",
          "correct": true
        },
        {
          "label": "C",
          "text": "Hidradenitis suppurativa",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tuberculosis of the breast",
          "correct": false
        }
      ],
      "correct_answer": "B. Mondor\u2019s disease",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1683764854419-QTDS008011IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Mondor\u2019s disease Mondor\u2019s disease is a variant of thrombophlebitis that involves the superficial veins of the anterior chest wall and breast. Frequently involved veins include the lateral thoracic vein, the thoraco-epigastric vein, and, less commonly, the superficial epigastric vein. Typically, a woman presents with acute pain in the lateral aspect of the breast or the anterior chest wall. A tender, firm cord is found to follow the distribution of one of the major superficial veins.</p>\n<p><strong>Highyeild:</strong></p><p>Zuska's Disease A rare inflammatory condition of the breast tissue that affects lactating women. Mondor's Disease A rare condition that causes thrombophlebitis of the subcutaneous veins in the chest or breast area. Hidradenitis suppurativa A chronic skin condition that causes painful, inflamed, and pus-filled lesions, typically in areas with sweat glands. Tuberculosis of the breast A rare form of tuberculosis that affects the breast tissue, usually in women of childbearing age.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A. Zuska\u2019s disease , also called recurrent periductal mastitis , is a condition of recurrent retro-areolar infections and abscesses. Option: C. Hidradenitis suppurativa of the nipple-areola complex or axilla is a chronic inflammatory condition that originates within the accessory areolar glands of Montgomery or the axillary sebaceous glands. When located in and about the nipple-areola complex, this disease may mimic other chronic inflammatory states, Paget\u2019s disease of the nipple, or invasive breast cancer. Option: D. Tuberculosis of the breast usually presents with multiple chronic abscesses and sinuses and a typical bluish, attenuated appearance of the surrounding skin and is usually associated with active pulmonary tuberculosis or tuberculous cervical adenitis.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8d3df363",
      "audio": ""
    },
    {
      "text": "A 53 - year - old woman comes to the office with a \"strange, itchy rash\" on her left breast, which has been present for the last month. The patient applied over-the-counter corticosteroid ointment to this rash with no relief of symptoms. She takes no medications. The patient's last menstrual period was 2 years ago. She has a history of hypertension that improved with weight loss and exercise. Physical examination shows an eczematous plaque on the left nipple and areola. Which conditions are most likely associated with this patient's finding?",
      "options": [
        {
          "label": "A",
          "text": "Adenocarcinoma",
          "correct": true
        },
        {
          "label": "B",
          "text": "Squamous cell carcinoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Papilloma Lymphoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Fibroadenoma",
          "correct": false
        }
      ],
      "correct_answer": "A. Adenocarcinoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Adenocarcinoma Adenocarcinoma, which refers to carcinoma that starts in glandular tissue , is generally the most common type of breast cancer and is also found in Paget disease. Breast cancer should be considered in a patient with no history of skin disease who develops a breast rash. Mammary Paget disease is suspected when a persistent, eczematous, and/or ulcerating rash is localized to the nipple and spreads to the areola. Other characteristic findings include vesicles, scales, bloody discharge, and nipple retraction . Patients experience pain, itching, and burning of the affected nipple and no resolution with topical corticosteroids. Approximately 85% of patients with Paget disease of the breast have underlying breast cancer, although a mass is not always palpable. The nipple changes of Paget disease are thought to be caused by the migration of neoplastic cells through the mammary ducts to the nipple surface. Further workup should include m ammography and biopsy .</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: B. Cutaneous squamous cell carcinoma typically results from infection with the human papillomavirus (e.g., genital/periungual region) or frequent sun exposure (e.g., head, neck, dorsum of the extremities). Primary squamous cell carcinoma of the breast is very rare. Option: C. Breast lymphoma is extremely rare and typically presents as a painless, palpable breast mass without cutaneous manifestations in a postmenopausal woman. Cutaneous lymphomas typically involve the trunk and/or extremities versus presenting as isolated breast lesions. Option: D. Fibroadenoma is a benign breast lesion that typically presents as a palpable, mobile, rubbery, firm breast mass without nipple changes.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e8081d72",
      "audio": ""
    },
    {
      "text": "A 58- year- old woman, gravida 1 para 1, comes for a routine health maintenance examination. The patient has been doing well and has no concerns. She breastfed her daughter for over 2 years. The patient has no chronic medical problems, and her only surgery was a caesarean section at age 20. Menarche was at age 14, and menopause occurred 4 years ago. She takes no medications and has no allergies. A cousin on the paternal side of her family died of breast cancer this year, and the patient is concerned about her own risk for breast cancer. Physical examination and screening mammography are normal. Which of the following historical findings is this patient's greatest risk factor for breast cancer?",
      "options": [
        {
          "label": "A",
          "text": "Age at menarche",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chronological age",
          "correct": true
        },
        {
          "label": "C",
          "text": "Duration of breastfeeding",
          "correct": false
        },
        {
          "label": "D",
          "text": "Family history of breast cancer",
          "correct": false
        }
      ],
      "correct_answer": "B. Chronological age",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Chronological age Women's lifetime risk of being diagnosed with breast cancer increases with age .</p>\n<p><strong>Highyeild:</strong></p><p>Other important risk factors include nulliparity, obesity, and prolonged hormone replacement therapy, all contributing to increased lifetime oestrogen exposure . In young patients, aggressive cancers are more likely caused by inherited genetic mutations (e.g., BRCA). Screening for breast cancer involves clinical breast examination and mammography. Most current guidelines suggest routine screening mammography at age >40 due to the increased risk of cancer with increased age.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A. Menarche after age 13 is associated with reduced breast cancer risk due to decreased lifetime oestrogen exposure. Option: C. Breastfeeding has a protective effect on breast cancer with a significant relative risk reduction for each year of breastfeeding. Option: D. The risk of breast cancer increases with a history of the disease in first-degree relatives. A cousin is a second-degree relative and is less likely to be a significant risk factor for this patient without any other affected family members</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d12cce9d",
      "audio": ""
    }
  ]
}